ClinicalTrials.gov has posted results from NCT04828135, a completed Phase 2 study using dual magnetic-resonance imaging to examine cardiopulmonary findings in people with persistent symptoms after COVID-19.
The registry reports actual enrolment of 18 participants and includes posted outcome information. Its small size limits conclusions about wider patient populations.
The registry entry supports reporting the measurements as research observations, not as proof that the imaging approach improves diagnosis or patient outcomes.
